NuCana plc

US$0.94As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NCNAHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (71.69%)
Div yield —
ROE (70.26%)
Biotechnology
Beta (5Y) 2.44
PE TTM —
TSR TTM (76.62%)
Mkt cap US$4.041M
ROIC (64.16%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.901
(3.93%)
14.65%
Hold 0|12|11|8|5
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.01
0.01
0.02
0.02
9.90%
9.34%
11.79%
11.23%
Revenue£M
0.269
0.276
0.282
0.298
7.35%
6.83%
8.08%
10.50%
Peers (US$4.041M)
Cap (US$)
PE
4.169M
—
3.863M
—
2.665M
—
Capital
TTM
5Y
10Y
Leveragex
1.243
(0.399)
(0.247)
EBIT/Intx
0.823
0.203
0.166
Own earn%
41.50
(69.45)
(95.32)
Sh yield%
18.51
41.46
40.93
Owners
Insiders/Inst%
12.94
23.97
Short interest%
1.56
SBC / revenue%
3.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
27–35
$1 testx
—
Incr. ROIC%
44